glp-1 drugs sleep apnea Ozempic and apnea: What the new research shows GLP-1 | Summary
Description
Tirzepatides dual agonist function targets both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
For context, only 4.2% of placebo participants achieved complete pain freedom
[PubMed] [Google Scholar] 166.Li L, Yang X, Tran D, Seo SK, Lu Y
5 As comparison, 70/30 mixed insulin aspart was shown to have a mean increased weight of 4.04 kg
Even at 0.5 mg, receptor activation begins and the body starts adapting to triple agonism
Cost : GLP-1 treatments can cost over $12,000 annually, while Metformin is far more affordable
